The Mount Sinai Health System’s largest celebration of the year took place on Thursday, May 8, as more than 1,300 guests, including leadership, staff, and supporters from all seven Mount Sinai hospitals gathered to dine, dance, and mingle at the 29th annual Crystal Party.
Top prospects in this year’s National Football League draft stopped by Kravis Children’s Hospital at Mount Sinai on Thursday, May 8, the first day of the draft. They delighted pediatric patients with smiles, NFL goody bags, and visits to their rooms and to The Zone, a therapeutic and educational play area.
Specific cellular pathways, along which genetic mutations occur, appear to play a key role in the development of autism spectrum disorders (ASD), according to new research from Icahn School of Medicine at Mount Sinai.
The findings, published online in the April 24, 2014, issue of The American Journal of Human Genetics, provide scientists with a better understanding of the complex genetic architecture involved in ASD, which has its roots in early brain development.
The Icahn School of Medicine at Mount Sinai is launching a unique Master’s program specifically geared to give health care leaders new knowledge and skills as they confront the challenges of delivering patient care in an era of unprecedented reform. The Master’s Program in Health Care Delivery Leadership is offered through the Department of Population Science and Policy and is currently accepting applications for its inaugural cohort that begins this fall.
When colleagues nominated Joshua Lasseigne, BSN, RN, CHPN, a hospice and palliative care nurse at The Mount Sinai Hospital for a clinical excellence award, they summarized his exceptional skills in a nomination letter. “He truly helps patients and families through the darkest hours of their lives with a soft voice of hope and strong loving hugs,” they wrote. “He has a passion for nursing, a sense of optimism, and is an excellent role model and mentor.”
More than 300 employees and patients of the Mount Sinai Health System recently gathered in the Guggenheim Atrium to celebrate the 30,000th participant in the BioMe Biobank. The Biobank collects de-identified DNA and plasma used for a variety of research purposes from consenting patients.